We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Link Between Aging and Fibrotic Pulmonary Disease Discovered

By LabMedica International staff writers
Posted on 09 Mar 2017
A study analyzing transcriptome biomarker data has shown evidence linking cellular senescence with idiopathic pulmonary fibrosis (IPF), suggesting that this fatal lung disease maybe involve a form of accelerated aging.

“IPF is a poorly understood disease, and its effects are devastating,” said study senior author Nathan LeBrasseur, PhD, of Mayo Clinic, “Individuals with IPF express difficulty completing routine activities. More...
There are currently no effective treatment options, and the disease leads to a dramatic decrease in health span and life span, with life expectancy after diagnosis between 3 to 5 years.”

Dr. LeBrasseur and his team, which included experts across several departments at Mayo Clinic, as well as Newcastle University Institute for Ageing and The Scripps Research Institute, studied the lung tissue of healthy individuals and of persons with mild, moderate, and severe IPF. The tissue samples were made available from the Lung Tissue Research Consortium.

They found that the markers of cellular senescence were higher in individuals with IPF, and senescent cell burden increased with the progression of the disease. They then demonstrated that factors secreted by senescent cells could drive inflammation and aberrant tissue remodeling and fibrosis – hallmarks of IPF.

“We discovered that senescent cells, which accumulate in the IPF lung, are a viable source of multiple factors that drive fibrotic activation,” explained lead author Marissa Schafer, PhD, postdoctoral fellow in Dr. LeBrasseur’s lab. According to Dr. LeBrasseur, the findings represent a conceptual shift in the way researchers think about IPD: “Up to this point, research efforts have largely focused on understanding the unique elements that contribute to IPF. Here, we are considering whether the biology of aging is accelerated in this aggressive disease. What we’ve found is that senescent cells are prevalent, secreting toxic molecules that affect healthy cells in that environment and are essentially promoting tissue fibrosis.”

Equipped with the findings from their studies of human lung tissue, the team then investigated the process in mice. They found that, much like in humans, mice with clinical features of IPF also demonstrated increased amounts of senescent cells. They used a genetic model programmed to make senescent cells self-destruct and a drug combination of dasatinib and quercetin, which, in previous studies conducted by Mayo Clinic, was shown to eliminate senescent cells. Results showed that clearing senescent cells from unhealthy mice improved measures of lung function and physical health, such as in exercise capacity on a treadmill. This suggests that targeting senescent cells could be a viable treatment option.

“We are exploring whether senolytic drugs, or drugs that can selectively kill senescent cells, can be used for the treatment of aging-associated conditions, including IPF,” said Dr. LeBrasseur, “More research is needed to validate this, and our goal is to move quickly from discovery to translation to application, and, ultimately, meet the unmet needs of our patients.”

The study, by Schafer MJ et al, was published online February 23, 2017, in the journal Nature Communications.


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining Management Software
DakoLink
New
Integrated Biochemical & Immunological System
Biolumi CX8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.